GENFIT
Develops therapies and diagnostics for patients with rare and severe liver diseases.
GNFT | PA
Overview
Corporate Details
- ISIN(s):
- FR0004163111 (+2 more)
- LEI:
- 969500XPWN2DMZQA5X73
- Country:
- France
- Address:
- 885 AVENUE EUGENE AVINEE, 59120 LOOS
- Website:
- https://www.genfit.com
Description
GENFIT is a biopharmaceutical company dedicated to developing therapeutic and diagnostic solutions for patients with rare and severe liver diseases characterized by high unmet medical needs. The company's primary focus is on Acute-on-Chronic Liver Failure (ACLF) and its associated conditions, such as acute decompensation (AD) and hepatic encephalopathy (HE). Leveraging a scientific heritage of over two decades, GENFIT is a pioneer in liver disease research and development, aiming to improve the lives of patients with these life-threatening conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-10 18:00 |
GENFIT : GNS561 montre une activité antitumorale prometteuse en combinaison thé…
|
French | 208.6 KB | ||
| 2025-12-10 18:00 |
GENFIT: GNS561 Shows Promising Antitumor Activity in Combination Therapy
|
English | 205.2 KB | ||
| 2025-11-27 18:00 |
GENFIT annonce la nomination d’un nouveau Directeur Médical
|
French | 150.1 KB | ||
| 2025-11-27 18:00 |
GENFIT Announces Appointment of new Chief Medical Officer
|
English | 161.2 KB | ||
| 2025-11-20 18:10 |
GENFIT Reports Third Quarter 2025 Financial Information and Provides a Corporat…
|
English | 176.6 KB | ||
| 2025-11-20 18:10 |
GENFIT : Information financière du troisième trimestre 2025 et point sur les ac…
|
French | 187.7 KB | ||
| 2025-11-20 18:00 |
GENFIT annonce la réalisation du retrait volontaire de ses « American Depositar…
|
French | 657.8 KB | ||
| 2025-11-20 18:00 |
GENFIT announces effectiveness of voluntary delisting of American Depositary Sh…
|
English | 777.4 KB | ||
| 2025-11-10 07:45 |
GENFIT signe un partenariat de recherche avec EVerZom pour faire progresser une…
|
French | 204.9 KB | ||
| 2025-11-10 07:45 |
GENFIT Enters Research Collaboration with EVerZom to Advance Exosome-based Rege…
|
English | 223.5 KB | ||
| 2025-11-10 07:30 |
GENFIT présente de nouvelles données précliniques prometteuses sur NTZ/G1090N d…
|
French | 315.9 KB | ||
| 2025-11-10 07:30 |
GENFIT Presents Promising New Preclinical Data on NTZ/G1090N for the Treatment …
|
English | 217.0 KB | ||
| 2025-10-30 21:00 |
GENFIT annonce son intention de procéder au retrait volontaire de la cotation d…
|
French | 639.8 KB | ||
| 2025-10-30 21:00 |
GENFIT announces intention to voluntarily delist American Depositary Shares fro…
|
English | 907.9 KB | ||
| 2025-10-28 22:10 |
GENFIT annonce des avancées dans ses programmes ACLF lors du congrès AASLD The …
|
French | 562.0 KB |
Automate Your Workflow. Get a real-time feed of all GENFIT filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GENFIT
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GENFIT via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-07-07 | N/A | Other | Buy | 5,300 | 19,488.10 EUR |
| 2023-07-06 | N/A | Other | Buy | 1,100 | 4,048.00 EUR |
| 2023-07-05 | N/A | Other | Buy | 10,000 | 37,061.00 EUR |
| 2023-07-03 | N/A | Other | Buy | 5,300 | 18,769.95 EUR |
Peer Companies
